Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaus Schultz

Showing results (181-190 of 310) with videos related to

Pageof 31
Sort By:
Nature Medicine|March 2, 2016
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancerAkash Kumar, Ilsa Coleman, Colm Morrissey, et al.
Neuro-Oncology|August 22, 2025
Multicenter basket trial for Central Nervous System tumors identifies activity of the CDK4/6 inhibitor abemaciclib in recurrent meningiomaThomas J Kaley, Christian Grommes, Elizabeth Coffee, et al.
JCO Precision Oncology|March 18, 2026
Genomic Features and Response to Poly(ADP-ribose) Polymerase Inhibition in Metastatic Castration-Resistant Prostate CancerJeffery C W Chang, Subhiksha Nandakumar, Konrad H Stopsack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2013
Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancerGopa Iyer, Hikmat Al-Ahmadie, Nikolaus Schultz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2019
Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung AdenocarcinomaJian Zhou, Francisco Sanchez-Vega, Raul Caso, et al.
Cancer Research Communications|February 8, 2024
Genomic Characterization and Clinical Outcomes of Patients with Peritoneal Metastases from the AACR GENIE Biopharma Collaborative Colorectal Cancer RegistryEnrique Sanz-Garcia, Samantha Brown, Jessica A Lavery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2021
Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and PathwaysSmita Sihag, Samuel C Nussenzweig, Henry S Walch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2026
Metastatic Trajectories in Non-Small Cell Lung Cancer Guide Local and Systemic TherapiesJonas Willmann, Edward Christopher Dee, Lizza E L Hendriks, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 9, 2018
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancerSebastian Mondaca, Matthew Margolis, Francisco Sanchez-Vega, et al.
Developmental Cell|May 26, 2026
An appendiceal cancer organoid biobank identifies phenotypic evolution and druggable dependencies of peritoneal carcinomatosisAhmed Mahmoud, Christine Sukhwa, Michael Giarrizzo, et al.
Pageof 31

Showing results (181-190 of 310) with videos related to

Sort By:
Pageof 31
Nature Medicine|March 2, 2016
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancerAkash Kumar, Ilsa Coleman, Colm Morrissey, et al.
Neuro-Oncology|August 22, 2025
Multicenter basket trial for Central Nervous System tumors identifies activity of the CDK4/6 inhibitor abemaciclib in recurrent meningiomaThomas J Kaley, Christian Grommes, Elizabeth Coffee, et al.
JCO Precision Oncology|March 18, 2026
Genomic Features and Response to Poly(ADP-ribose) Polymerase Inhibition in Metastatic Castration-Resistant Prostate CancerJeffery C W Chang, Subhiksha Nandakumar, Konrad H Stopsack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2013
Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancerGopa Iyer, Hikmat Al-Ahmadie, Nikolaus Schultz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2019
Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung AdenocarcinomaJian Zhou, Francisco Sanchez-Vega, Raul Caso, et al.
Cancer Research Communications|February 8, 2024
Genomic Characterization and Clinical Outcomes of Patients with Peritoneal Metastases from the AACR GENIE Biopharma Collaborative Colorectal Cancer RegistryEnrique Sanz-Garcia, Samantha Brown, Jessica A Lavery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2021
Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and PathwaysSmita Sihag, Samuel C Nussenzweig, Henry S Walch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2026
Metastatic Trajectories in Non-Small Cell Lung Cancer Guide Local and Systemic TherapiesJonas Willmann, Edward Christopher Dee, Lizza E L Hendriks, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 9, 2018
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancerSebastian Mondaca, Matthew Margolis, Francisco Sanchez-Vega, et al.
Developmental Cell|May 26, 2026
An appendiceal cancer organoid biobank identifies phenotypic evolution and druggable dependencies of peritoneal carcinomatosisAhmed Mahmoud, Christine Sukhwa, Michael Giarrizzo, et al.
Pageof 31